# OnCo record funda-meric-bernstam (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/funda-meric-bernstam/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "funda-meric-bernstam" ;
  schema:name "Funda Meric-Bernstam"@en ;
  schema:description "Funda Meric-Bernstam runs the world's largest phase 1 programme and led the tumour-agnostic HER2 ADC study."@en ;
  schema:url <https://onco.cc/people/funda-meric-bernstam/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://faculty.mdanderson.org/search?q=Funda%20Meric-Bernstam>, <https://pubmed.ncbi.nlm.nih.gov/?term=Meric-Bernstam%20F%5BAuthor%5D>, <https://scholar.google.com/scholar?q=Funda%20Meric-Bernstam> ;
  schema:jobTitle "Chair, Investigational Cancer Therapeutics, MD Anderson" ;
  onco:technologies <https://onco.cc/technologies/cgp/>, <https://onco.cc/technologies/companion-diagnostic/> ;
  onco:targets <https://onco.cc/targets/her2/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab-deruxtecan/> ;
  onco:institutions <https://onco.cc/institutions/md-anderson/> ;
  onco:trials <https://onco.cc/trials/destiny-pantumor02/> ;
  schema:affiliation <https://onco.cc/institutions/md-anderson/> .